Medpace Holdings, Inc.
MX ˙ BMV ˙ US58506Q1094
SecurityMX:MEDP / Medpace Holdings, Inc.
InstitutionVerition Fund Management LLC
Latest Disclosed Ownership7,440 shares
Latest Disclosed Value $ 3,572,614
Verition Fund Management LLC reports 48.21% increase in ownership of MEDP / Medpace Holdings, Inc.

On May 15, 2026 - Verition Fund Management LLC filed a 13F-HR form disclosing ownership of 7,440 shares of Medpace Holdings, Inc. (MX:MEDP) valued at $3,572,614 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 5,020 shares of Medpace Holdings, Inc.. This represents a change in shares of 48.21% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MEDPACE HLDGS COM 58506Q109 7,440 2,420 48.21 3,573 26.71 0.0232
2026-02-13 2025-12-31 13F MEDPACE HLDGS COM 58506Q109 5,020 -11,257 -69.16 2,819 -66.31 0.0111
2025-11-14 2025-09-30 13F MEDPACE HLDGS COM 58506Q109 16,277 10,504 181.95 8,369 362.07 0.0345
2025-08-14 2025-06-30 13F MEDPACE HLDGS COM 58506Q109 5,773 2,364 69.35 1,812 74.47 0.0081
2025-05-15 2025-03-31 13F MEDPACE HLDGS COM 58506Q109 3,409 1,532 81.62 1,039 66.61 0.0048
2025-02-14 2024-12-31 13F MEDPACE HLDGS COM 58506Q109 1,877 1,877 624 0.0025
2024-11-14 2024-09-30 13F MEDPACE HLDGS COM 58506Q109 0 -2,276 -100.00 0 -100.00
2024-08-14 2024-06-30 13F MEDPACE HLDGS COM 58506Q109 2,276 1,385 155.44 937 160.28 0.0051
2024-05-14 2024-03-31 13F MEDPACE HLDGS COM 58506Q109 891 891 360 0.0025
2023-11-14 2023-09-30 13F MEDPACE HLDGS COM 58506Q109 0 -6,435 -100.00 0 -100.00
2023-08-14 2023-06-30 13F MEDPACE HLDGS COM 58506Q109 6,435 4,543 240.12 1,545 335.21 0.0206
2023-05-15 2023-03-31 13F MEDPACE HLDGS COM 58506Q109 1,892 1,892 356 0.0049
2019-02-14 2018-12-31 13F MEDPACE HLDGS COM 58506Q109 0 -25,873 -100.00 0 -100.00
2018-11-14 2018-09-30 13F MEDPACE HLDGS COM 58506Q109 25,873 25,873 1,550 0.0555
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.